Literature DB >> 22452620

Randomised clinical trial: enteral nutrition does not improve the long-term outcome of alcoholic cirrhotic patients with jaundice.

B Dupont1, T Dao, C Joubert, C Dupont-Lucas, R Gloro, E Nguyen-Khac, E Beaujard, P Mathurin, E Vastel, M Musikas, I Ollivier, M-A Piquet.   

Abstract

BACKGROUND: Malnutrition and jaundice are independent prognostic factors in cirrhosis. AIM: To assess the impact of enteral nutrition on the survival of alcoholic cirrhotic patients with jaundice but without acute alcoholic hepatitis.
METHODS: The study was a multicentre prospective randomised controlled trial comparing effects of enteral nutrition vs. a symptomatic support in patients with alcoholic cirrhosis and jaundice (bilirubin ≥51 µmol/L) but without severe acute alcoholic hepatitis. A total of 99 patients were randomised to receive either the conventional symptomatic treatment (55 patients) or the symptomatic support associated with 35 kcal/Kg/day of enteral nutrition during 4 weeks followed by an oral nutritional support during 2 months (44 patients). Randomisation was stratified on nutritional status. One-year survival curves were compared using the Kaplan-Meier method and Logrank test.
RESULTS: Populations in both arms were similar. One-year survival was similar in the overall population (27/44 patients (61.4%) in the enteral nutrition arm vs. 36/55 (65.5%) in the control arm; Logrank P = 0.60) and in the subgroup suffering from malnutrition [18/29 patients (62.1%) in the enteral nutrition arm vs. 20/32 (62.5%) in the control arm; Logrank P = 0.99]. There was no statistical difference for bilirubin, prothrombin rate, Child-Pugh score, albumin or nutritional assessment. Complications during treatment (bleeding, encephalopathy, infection) occurred in 23% of patients in the enteral nutrition group (10/44) vs. 16% (9/55) of the control patients (P = 0.59).
CONCLUSION: Enteral nutrition does not improve the survival and hepatic or nutritional parameters of cirrhotic patients with jaundice.
© 2012 Blackwell Publishing Ltd.

Entities:  

Mesh:

Year:  2012        PMID: 22452620     DOI: 10.1111/j.1365-2036.2012.05075.x

Source DB:  PubMed          Journal:  Aliment Pharmacol Ther        ISSN: 0269-2813            Impact factor:   8.171


  12 in total

1.  ESPEN guideline on clinical nutrition in liver disease.

Authors:  Mathias Plauth; William Bernal; Srinivasan Dasarathy; Manuela Merli; Lindsay D Plank; Tatjana Schütz; Stephan C Bischoff
Journal:  Clin Nutr       Date:  2019-01-16       Impact factor: 7.324

Review 2.  Sarcopenia in Alcoholic Liver Disease: Clinical and Molecular Advances.

Authors:  Jaividhya Dasarathy; Arthur J McCullough; Srinivasan Dasarathy
Journal:  Alcohol Clin Exp Res       Date:  2017-07-11       Impact factor: 3.455

Review 3.  Pharmacological interventions for alcoholic liver disease (alcohol-related liver disease): an attempted network meta-analysis.

Authors:  Elena Buzzetti; Maria Kalafateli; Douglas Thorburn; Brian R Davidson; Maja Thiele; Lise Lotte Gluud; Cinzia Del Giovane; Gro Askgaard; Aleksander Krag; Emmanuel Tsochatzis; Kurinchi Selvan Gurusamy
Journal:  Cochrane Database Syst Rev       Date:  2017-03-31

Review 4.  Nutrition support in hospitalised adults at nutritional risk.

Authors:  Joshua Feinberg; Emil Eik Nielsen; Steven Kwasi Korang; Kirstine Halberg Engell; Marie Skøtt Nielsen; Kang Zhang; Maria Didriksen; Lisbeth Lund; Niklas Lindahl; Sara Hallum; Ning Liang; Wenjing Xiong; Xuemei Yang; Pernille Brunsgaard; Alexandre Garioud; Sanam Safi; Jane Lindschou; Jens Kondrup; Christian Gluud; Janus C Jakobsen
Journal:  Cochrane Database Syst Rev       Date:  2017-05-19

Review 5.  Nutritional assessment in cirrhotic patients with hepatic encephalopathy.

Authors:  Fernando Gomes Romeiro; Laís Augusti
Journal:  World J Hepatol       Date:  2015-12-28

Review 6.  Sarcopenia from mechanism to diagnosis and treatment in liver disease.

Authors:  Srinivasan Dasarathy; Manuela Merli
Journal:  J Hepatol       Date:  2016-08-08       Impact factor: 25.083

7.  Interventions to improve sarcopenia in cirrhosis: A systematic review.

Authors:  Maliha Naseer; Erica P Turse; Ali Syed; Francis E Dailey; Mallak Zatreh; Veysel Tahan
Journal:  World J Clin Cases       Date:  2019-01-26       Impact factor: 1.337

Review 8.  Assessment of Malnutrition, Sarcopenia and Frailty in Patients with Cirrhosis: Which Tools Should We Use in Clinical Practice?

Authors:  Benjamin Buchard; Yves Boirie; Lucie Cassagnes; Géraldine Lamblin; A Coilly; Armando Abergel
Journal:  Nutrients       Date:  2020-01-09       Impact factor: 5.717

9.  Adherence to Oral Nutritional Supplements After Being Discharged from the Hospital is Low but Improves Outcome in Patients with Advanced Chronic Liver Disease.

Authors:  Lubomir Skladany; Jana Vnencakova; Lukas Laffers; Beata Skvarkova; Eva Hrubá; Pavol Molcan; Tomas Koller
Journal:  Patient Prefer Adherence       Date:  2021-01-05       Impact factor: 2.711

Review 10.  Nutritional support in chronic liver disease and cirrhotics.

Authors:  Ravi Shergill; Wajahat Syed; Syed Ali Rizvi; Ikjot Singh
Journal:  World J Hepatol       Date:  2018-10-27
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.